South America Synthetic Biology Market Forecast to 2028

South America Synthetic Biology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Products (Enzymes, Chassis Organisms, Oligonucleotides, and Xeno-Nucleic Acids), Technology (Measurement & Modeling, Cloning & Sequencing, Genome Engineering, Gene Synthesis, Nanotechnology, and Others), and Application (Medical Applications, Industrial Applications, Food and Agriculture, Environmental Applications, and Others)

Report Code : BMIRE00025393 | Region : LAMEA | Industry : Biotechnology | Published Date : 15/Jul/2022

The SAM synthetic biology market is expected to grow from US$ 450.24 million in 2021 to US$ 1,514.03 million by 2028; it is estimated to grow at a CAGR of 18.9% from 2021 to 2028.

Synthetic biology is an emerging concept that has numerous applications in the chemicals, agriculture, pharmaceuticals, and energy industries. Various start-ups offer gene synthesis products/services for biological processes. For example, Benchling provides CAD tools, GenScript offers gene synthesis, Ginkgo Bioworks assists in organism engineering, Transcriptis (a bioinformatics company) offers solutions facilitating cloud labs/automation, and Glowee offers consumer products. Amid the adverse effects of the COVID-19 pandemic on start-up performance, the bioeconomy accelerated in the first half of 2020. 56 synthetic biology businesses raised more than US$ 3 billion in equity financing in the first half of 2020, compared to 65 companies raising US$ 1.9 billion during the same period in 2020. The new generation of biopharma businesses uses synthetic biology to improve cell treatment and gene therapy and support early cancer detection. With such rising investments by companies, the demand for synthetic biology-based new techniques is increasing, thereby driving the synthetic biology market growth across the region.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM synthetic biology market . The SAM synthetic biology market is expected to grow at a notable CAGR during the forecast period.

SAM Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

SAM Synthetic Biology Market Segmentation

The SAM synthetic biology market is analyzed based on products, technology, application, and country. Based on products, the market is segmented into enzymes, chassis organisms, oligonucleotides, and xeno-nucleic acids. The oligonucleotides segment dominated the market in 2020 and is expected to be fastest growing during the forecast period. Based on technology, the market is segmented into measurement & modeling, cloning & sequencing, genome engineering, gene synthesis, nanotechnology, and others. The gene synthesis segment dominated the market in 2020, while the genome engineering segment is expected to be fastest growing during the forecast period. Based on application, the market is segmented into medical applications, industrial applications, food and agriculture, environmental applications, and others. The medical applications segment dominated the market in 2020 and is expected to be fastest growing during the forecast period. The SAM synthetic biology market is segmented into Brazil, Argentina, and Rest of SAM.

Agilent Technologies, Inc.; Amyris; Codexis; Genscript Biotech corporation; Integrated DNA Technologies; Merck KGaA; New England Biolabs; Novozymes A/S; Thermo Fisher Scientific; and Twist Bioscience are among the leading companies in the SAM synthetic biology market.

Oligonucleotides Segment to Dominate SAM Synthetic Biology Market During 2021-2028

According to a new market research study on “SAM Synthetic Biology Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Products, Technology, and Application ” is expected to reach US$ 1,514.03 million by 2028 from US$ 450.24 million in 2021. The market is estimated to grow at a CAGR of 18.9% from 2021 to 2028. The report provides trends prevailing in the SAM synthetic biology market along with the drivers and restraints pertaining to the market growth. Increasing investments in synthetic biology is the major factor driving the growth of the SAM synthetic biology market . However, renewed regulations for biotechnology may hamper the growth of the market hinders the growth of SAM synthetic biology market .

The SAM synthetic biology market is analyzed based on products, technology, application, and country. Based on products, the market is segmented into enzymes, chassis organisms, oligonucleotides, and xeno-nucleic acids. The oligonucleotides segment dominated the market in 2020 and is expected to be fastest growing during forecast period. Based on technology, the market is segmented into measurement & modeling, cloning & sequencing, genome engineering, gene synthesis, nanotechnology, and others. The gene synthesis segment dominated the market in 2020 and genome engineering is expected to be fastest growing during forecast period. Based on application, the market is segmented into medical applications, industrial applications, food and agriculture, environmental applications, and others. The medical applications segment dominated the market in 2020 and is expected to be fastest growing during forecast period. Based on country, the SAM synthetic biology market is segmented into the Brazil, Argentina, and Rest of SAM.

Agilent Technologies, Inc.; Amyris; Codexis; Genscript Biotech corporation; Integrated DNA Technologies; Merck KGaA; New England Biolabs; Novozymes A/S; Thermo Fisher Scientific; and Twist Bioscience are among the leading companies in the SAM synthetic biology market . The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Merck Advances BioProcessing Capabilities with Acquisition of MAST Platform from Lonza, a Leading Automated Bioreactor Sampling System. The acquisition of the MAST platform is another milestone to accelerate innovation in Merck’s Process Solutions business unit.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 SAM Synthetic Biology Market – By Product

1.3.2 SAM Synthetic Biology Market – By Technology

1.3.3 SAM Synthetic Biology Market – By Application

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. SAM Synthetic Biology Market – Market Landscape

4.1 Overview

4.2 SAM PEST Analysis

4.3 Experts Opinion

5. SAM Synthetic Biology Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Investments in Synthetic Biology

5.1.2 Rising Number of Start-Ups

5.2 Key Market Restraints

5.2.1 Renewed Regulations for Biotechnology

5.3 Key Market Opportunities

5.3.1 Collaboration Between Companies

5.4 Future Trends

5.4.1 Advanced Synthetic Biology

5.5 Impact Analysis

6. Synthetic Biology Market– SAM Analysis

6.1 SAM Synthetic Biology Market Revenue Forecast and Analysis

7. SAM Synthetic Biology Market Analysis – By Product

7.1 Overview

7.2 SAM Synthetic Biology Market, By Product, 2021 & 2028 (%)

7.3 Enzymes

7.3.1 Overview

7.3.2 Enzyme: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Oligonucleotides

7.4.1 Overview

7.4.2 Oligonucleotide: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Chassis Organisms

7.5.1 Overview

7.5.2 Chassis Organisms: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

7.6 Xeno-Nucleic Acids

7.6.1 Overview

7.6.2 Xeno-Nucleic Acids: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

8. SAM Synthetic Biology Market Analysis – By Technology

8.1 Overview

8.2 SAM Synthetic Biology Market Share by Technology - 2021 & 2028 (%)

8.3 Gene Synthesis

8.3.1 Overview

8.3.2 Gene Synthesis: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

8.4 Genome Engineering

8.4.1 Overview

8.4.2 Genome Engineering: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

8.5 Measurement and Modeling

8.5.1 Overview

8.5.2 Measurement and Modeling: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

8.6 Cloning and Sequencing

8.6.1 Overview

8.6.2 Cloning and Sequencing: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

8.7 Nanotechnology

8.7.1 Overview

8.7.2 Nanotechnology: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9. SAM Synthetic Biology Market Analysis – By Application

9.1 Overview

9.2 SAM Synthetic Biology Market Share by Application - 2021 & 2028 (%)

9.3 Medical Applications

9.3.1 Overview

9.3.2 Medical Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.3.2.1 Drug Discovery and Therapeutics

9.3.2.1.1 Overview

9.3.2.1.2 Drug Discovery and Therapeutics: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.3.2.2 Pharmaceuticals

9.3.2.2.1 Overview

9.3.2.2.2 Pharmaceuticals: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.4 Industrial Applications

9.4.1 Overview

9.4.2 Industrial Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.5 Food & Agriculture

9.5.1 Overview

9.5.2 Food & Agriculture: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.6 Environmental Applications

9.6.1 Overview

9.6.2 Environmental Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

10. SAM Synthetic Biology Market – Country Analysis

10.1 SAM: Synthetic Biology Market

10.1.1 Overview

10.1.2 SAM: Synthetic Biology Market, by Country, 2021 & 2028 (%)

10.1.2.1 Brazil: Synthetic Biology Market- Revenue and Forecasts To 2028 (US$ Million)

10.1.2.1.1 Overview

10.1.2.1.2 Brazil: Synthetic Biology Market- Revenue and Forecasts To 2028 (US$ Million)

10.1.2.1.3 Brazil: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

10.1.2.1.4 Brazil: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

10.1.2.1.5 Brazil: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

10.1.2.1.6 Brazil: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

10.1.2.1.7 Brazil: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

10.1.2.2 Argentina: Synthetic Biology Market- Revenue and Forecasts To 2028 (US$ Million)

10.1.2.2.1 Overview

10.1.2.2.2 Argentina: Synthetic Biology Market- Revenue and Forecasts To 2028 (US$ Million)

10.1.2.2.3 Argentina: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

10.1.2.2.4 Argentina: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

10.1.2.2.5 Argentina: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

10.1.2.2.6 Argentina: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

10.1.2.3 Rest of SAM: Synthetic Biology Market - Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1 Overview

10.1.2.3.2 Rest of SAM: Synthetic Biology Market - Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3 Rest of SAM: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

10.1.2.3.4 Rest of SAM: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

10.1.2.3.5 Rest of SAM: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

10.1.2.3.6 Rest of SAM: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

11. Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 Thermo Fisher Scientific Inc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Agilent Technologies, Inc.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 MERCK KGaA

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 New England Biolabs

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Integrated DNA Technologies

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Twist Bioscience

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 GenScript Biotech Corporation

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Novozymes A/S

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Codexis

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Amyris Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. SAM Synthetic Biology Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2. Brazil: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

Table 3. Brazil: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

Table 4. Brazil: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

Table 5. Argentina: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

Table 6. Argentina: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

Table 7. Argentina: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

Table 8. Argentina: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

Table 9. Rest of SAM: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

Table 10.   Rest of SAM: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

Table 11.   Rest of SAM: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

Table 12.   Rest of SAM: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

Table 13.   Organic Developments

Table 14.   Inorganic Developments

Table 15.   Glossary of Terms

LIST OF FIGURES.

Figure 1. SAM Synthetic Biology Market Segmentation

Figure 2. SAM Synthetic Biology Market, By Country

Figure 3. SAM Synthetic Biology Market Overview

Figure 4. SAM Synthetic Biology Market, By Product

Figure 5. SAM Synthetic Biology Market, By Country

Figure 7. SAM: PEST Analysis

Figure 8. Experts Opinion

Figure 9. SAM Synthetic Biology Market: Impact Analysis of Drivers and Restraints

Figure 10.   SAM Synthetic Biology Market– Revenue Forecast and Analysis

Figure 11.   SAM Synthetic Biology Market, by Product, 2021 & 2028 (%)

Figure 12.   SAM Enzymes: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.   SAM Oligonucleotide: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.   SAM Chassis Organisms: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.   SAM Xeno-Nucleic Acids: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.   SAM Synthetic Biology Market Share by Technology - 2021 & 2028 (%)

Figure 17.   SAM Gene Synthesis: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 18.   SAM Genome Engineering: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.   SAM Measurement and Monitoring: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.   SAM Cloning and Sequencing: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.   SAM Nanotechnology: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.   SAM Others: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23.   SAM Synthetic Biology Market Share by Application - 2021 & 2028 (%)

Figure 24.   SAM Medical Applications: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25.   SAM Drug Discovery and Therapeutics: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26.   SAM Pharmaceuticals: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 27.   SAM Industrial Applications: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28.   SAM Food & Agriculture: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 29.   SAM Environmental Applications: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30.   SAM Others: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31.   SAM: Synthetic Biology Market, Revenue Overview, by Country, 2021 (US$ Million)

Figure 32.   SAM: Synthetic Biology Market, by Country, 2021 & 2028 (%)

Figure 33.   Brazil: Synthetic Biology Market- Revenue and Forecasts To 2028 (US$ Million)

Figure 34.   Argentina: Synthetic Biology Market- Revenue and Forecasts To 2028 (US$ Million)

Figure 35.   Rest of SAM: Synthetic Biology Market - Revenue and Forecast to 2028 (US$ Million)

The List of Companies - South America Synthetic Biology Market

● Agilent Technologies, Inc.

● Amyris

● Codexis

● Genscript Biotech corporation

● Integrated DNA Technologies

● Merck KGaA

● New England Biolabs

● Novozymes A/S

● Thermo Fisher Scientific

● Twist Bioscience

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM synthetic biology market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the SAM synthetic biology market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the synthetic biology market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP